Conclusion of a non-exclusive rebate agreement pursuant to Section 130a(8) of the German Social Code Book V for the active substance teduglutide, ATC A16AX08, for the period 01/06/2026 to 31/05/2028 (plus option to extend once by 12 months)

Summary

The tender concerns the conclusion of a non-exclusive rebate agreement for medicines containing teduglutide for the period 01/06/2026 to 31/05/2028, with an option to extend once by 12 months. This is a pharmaceutical supply tender. The bidder must submit the required contract documents and accept DAK-Gesundheit’s contractual terms. Exact qualification and compliance requirements must be checked in the tender documents.